share_log

Medicenna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fahar Merchant(31.5%),Rosemina Merchant(31.5%), etc.

SEC ·  Feb 10, 2022 14:48
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more